Diabetic Retinopathy Screening and Registration in Europe—Narrative Review
Citations Over TimeTop 16% of 2021 papers
Abstract
Diabetic retinopathy (DR) is a leading cause of preventable vision impairment and blindness in the European Region. Despite the fact that almost all European countries have some kind of prophylactic eye examination for people with diabetes, the examinations are not properly arranged and are not organized according to the principles of screening in medicine. In 2021, the current COVID-19 pandemic moved telemedicine to the forefront healthcare services. Due to that, a lot more patients could benefit from comfortable and faster access to ophthalmology specialist care. This study aimed to conduct a narrative literature review on current DR screening programs and registries in the European Union for the last 20 years. With the implementation of telemedicine in daily medical practice, performing screening programs became much more attainable. Remote assessment of retinal pictures simultaneously saves countries time, money, and other resources.
Related Papers
- → Telemedicine Application and Assessment During the COVID-19 Pandemic(2022)13 cited
- Diabetic retinopathy: newer therapies to prevent blindness.(1992)
- → The Various Methods on Early Stage Detection of Diabetic Retinopathy(2019)1 cited
- → STUDY ON HOW THE TELEMEDICINE HAS MADE IT EFFECTIVE DURING THIS PANDEMIC, COVID -19(2021)
- → The Kilimanjaro Diabetic Programme: the development of a sustainable regional eye health screening program to prevent blindness among diabetic patients due to diabetic retinopathy(2012)